Navigation Links
HPV eradicated by AHCC supplement, preclinical study suggests

(March 23, 2014, Beaverton, OR) Treating cervical cancer cells with AHCC led to the eradication of HPV, human papillomavirus, as well as a decrease in the rate of tumor growth in-vitro and in-vivo, in research presented at the Society of Gynecological Oncology 45th Annual Meeting on Women's Cancer in Tampa, Florida. The study was led by Dr. Judith A. Smith, Pharm.D., at the University of Texas Health Science Center (UTHealth) Medical School at Houston.

In the study cervical cancer cells were treated with AHCC and incubated for 72 hours with sampling every 24 hours. The study was then repeated in two orthotopic mouse models, one HPV positive and other HPV negative control. The HPV expression was eradicated with once daily AHCC dosing for 90 days with durable response after 30 day observation off treatment. Dr. Smith then repeated the study to confirm findings and added sampling for correlative testing of immune markers to determine the mechanism by which AHCC eradicates the HPV virus.

These data suggest AHCC can eliminate HPV infections and may have a role in the prevention of HPV-related cancers. A confirmatory pilot study in HPV+ women is underway at UTHealth Women's Center.

"The results of this study were very encouraging," said Dr. Smith, Associate Professor at the UTHealth Medical School. "This study, initiated in 2008, shows that by itself AHCC has the potential to treat the HPV infection," she said. Smith's previous study evaluated AHCC integration with common chemotherapy agents used for the treatment of ovarian cancer, to screen for potential drug interactions and improvement in activity.

AHCC works as an immunotherapy, which is a treatment that uses a body's own immune system to help fight disease. Human and in-vivo studies have shown that AHCC increases the number and/or activity of Natural Killer (NK) cells, dendritic cells, and cytokines, which enable the body to effectively respond to infections and block the proliferation of tumors.

HPV (human papilloma virus) is the most common sexually transmitted virus in the United States. Up to 70% of sexually active adults will acquire HPV at some point in their lives. Human papillomavirus DNA has been detected in 99.7% of cervical cancer biopsies, yielding the largest causative relationship of any cancer. (1) According to the CDC several other types of cancer are also HPV related, including: 95% of anal cancer; 60% of oropharyngeal cancer; 65% of vaginal cancer; 50% of vulvar cancer; and 35% of penile cancer.

"I was intrigued by research presented at the annual AHCC symposium in Sapporo (2) showing the immune modulating effect of AHCC on other rare infections, and was eager to study the possibilities in treating the HPV infection associated with cervical cancer," said Dr. Smith.

"AHCC is a common, well tolerated nutritional supplement that has been used for decades in Japan, I am very excited to be pursuing a nutritional approach to trying to find a treatment for HPV infections," said Dr. Smith, whose research is on drug development for gynecologic cancers and conditions with a specific focus on drug interactions/drug resistance and integration of herbal and nutritional supplements for treatment of cancer.

"We had previously demonstrated an antiretroviral regimen that successfully eradicated the HPV infection but wanted to develop a more benign protocol, since these medications have a number of side effects," Dr. Smith continued.


Contact: John Carney or Julie McQuain
JMPR Associates, Inc.

Related medicine news :

1. New L-Carnitine and Green Coffee Bean Supplement, L-Carnitine Plus Now Available
2. Nutralife Health Products Inc. Announces Launch of New Website for its Revolutionary Joint Supplement, JointRite
3. Successful Dieter Starts Gold Coast With Revolutionary Weight Loss Supplement, Garcinia Cambogia
4. PhenObestin 37.5, a Pharmaceutical Grade Dietary Supplement, Urges Dieters to Lose Weight Without Experiencing Harmful Side Effects
5. LifeBotanica's Groundbreaking Anti-Aging Supplement, AGE DEFYING, Introduced
6. HyperGH 14x, the Natural Supplement, is Finally Available at to Boost Muscle Growth Naturally and Safely
7. Preclinical data support ongoing clinical trials testing IDO inhibitors as a treatment for cancer
8. Genetically-engineered preclinical models predict pharmacodynamic response
9. Preclinical study identifies master proto-oncogene that regulates ovarian cancer metastasis
10. Preclinical tests shows agent stops slippery proteins from binding, causing Ewing sarcoma
11. Mayo Clinic: Preclinical tests may lead to new approach to treat CNS lymphoma
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... ... their Black Friday sale a week early, offering 40% off select bras and ... intimate apparel industry through both mobile fit technology and the latest fashion, quickly ...
(Date:11/24/2015)... ... November 24, 2015 , ... DMG Productions announced that they will ... first quarter 2016 via Discovery Channel. Dates and show times TBA. , Aphria, Inc., ... in the business of producing and supplying medical marijuana pursuant to the Marijuana for ...
(Date:11/24/2015)... City, UT (PRWEB) , ... November 24, 2015 , ... ... Forbes Magazine. For a business, it is critical that the first impression be positive ... business, they are not likely to buy anything or want to return. They will ...
(Date:11/24/2015)... Richey, FL (PRWEB) , ... November 24, 2015 , ... ... deems a growing epidemic as deaths from prescription opioids in the United States grew ... and cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal ...
(Date:11/24/2015)... ALEXANDRIA, VA (PRWEB) , ... November 24, 2015 ... ... encourages people across the United States to support their local poison centers through ... been designated as #GivingTuesday: calls it “a day that inspires people to ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... -- The uptake of recently approved and pipeline premium products ... market growth to 2021, says GBI Research . ... for Type 1 Diabetes Mellitus (T1DM), will be a key driver of ... --> The uptake of recently approved and pipeline premium ... of market growth to 2021, says GBI Research ...
(Date:11/24/2015)... 24, 2015   Renowned ... deliver s advice and insights on ... More than 50% of Dubai ... according to the DHA   femMED launches comprehensive solutions for ... Dubai residents are not consuming enough to keep ...
(Date:11/24/2015)...  Freudenberg Medical has developed specialty tubing for an inexpensive, ... facilities. Africa and ... Nevertheless, prompt diagnosis is important to treat those affected and ... the help of a portable mini-lab or "lab on a ... affected areas and perform rapid testing for HIV. They do ...
Breaking Medicine Technology: